Search research articles
Contact Us
Filters
Showing results (71-80 of 92) with videos related to
Page
of 10
Sort By:
Hematological Oncology
|
July 13, 2016
Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma
Barbara Pro, Steven M Horwitz, H Miles Prince, et al.
Clinical Colorectal Cancer
|
June 4, 2016
Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice
Martin Wilhelm, Lothar Mueller, M Craig Miller, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences
|
September 6, 2023
Virtual reality simulation training in stroke thrombectomy centers with limited patient volume-Simulator performance and patient outcome
Olav Søvik, Arnstein Tveiten, Halvor Øygarden, et al.
Journal of Hematology & Oncology
|
January 25, 2014
Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses
Bertrand Coiffier, Barbara Pro, H Miles Prince, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2012
Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy
Bertrand Coiffier, Barbara Pro, H Miles Prince, et al.
Haematologica
|
May 9, 2020
Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study
Franck Morschhauser, Kamal Bouabdallah, Stephan Stilgenbauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2009
Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study
Andreas Engert, Volker Diehl, Jeremy Franklin, et al.
Polymers
|
January 1, 2020
Hydrofilm Polyurethane Films Reduce Radiation Dermatitis Severity in Hypofractionated Whole-Breast Irradiation: An Objective, Intra-Patient Randomized Dual-Center Assessment
Leonard Christopher Schmeel, David Koch, Frederic Carsten Schmeel, et al.
Lancet (London, England)
|
August 11, 2012
Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study
Hannes Wandt, Kerstin Schaefer-Eckart, Knut Wendelin, et al.
Cancer Investigation
|
September 20, 2006
Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
Ulrich J M Mey, Katjana S Orlopp, Dimitri Flieger, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 92) with videos related to
Sort By:
Page
of 10
Hematological Oncology
|
July 13, 2016
Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma
Barbara Pro, Steven M Horwitz, H Miles Prince, et al.
Clinical Colorectal Cancer
|
June 4, 2016
Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice
Martin Wilhelm, Lothar Mueller, M Craig Miller, et al.
Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences
|
September 6, 2023
Virtual reality simulation training in stroke thrombectomy centers with limited patient volume-Simulator performance and patient outcome
Olav Søvik, Arnstein Tveiten, Halvor Øygarden, et al.
Journal of Hematology & Oncology
|
January 25, 2014
Romidepsin for the treatment of relapsed/refractory peripheral T-cell lymphoma: pivotal study update demonstrates durable responses
Bertrand Coiffier, Barbara Pro, H Miles Prince, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2012
Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy
Bertrand Coiffier, Barbara Pro, H Miles Prince, et al.
Haematologica
|
May 9, 2020
Clinical activity of abemaciclib in patients with relapsed or refractory mantle cell lymphoma - a phase II study
Franck Morschhauser, Kamal Bouabdallah, Stephan Stilgenbauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 26, 2009
Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study
Andreas Engert, Volker Diehl, Jeremy Franklin, et al.
Polymers
|
January 1, 2020
Hydrofilm Polyurethane Films Reduce Radiation Dermatitis Severity in Hypofractionated Whole-Breast Irradiation: An Objective, Intra-Patient Randomized Dual-Center Assessment
Leonard Christopher Schmeel, David Koch, Frederic Carsten Schmeel, et al.
Lancet (London, England)
|
August 11, 2012
Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study
Hannes Wandt, Kerstin Schaefer-Eckart, Knut Wendelin, et al.
Cancer Investigation
|
September 20, 2006
Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
Ulrich J M Mey, Katjana S Orlopp, Dimitri Flieger, et al.
Page
of 10